DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease
Authors:
- 1 June 2015
- journal article
- review article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 776, 2-8
Abstract
No abstract availableKeywords
Funding Information
- Association Nationale de la Recherche et de la Technologie
- Association Française contre les Myopathies (2008 N° 12008)
- French Muscular Dystrophy Association
- Agence Nationale de la Recherche (ANR-07-RIB-020-02)
This publication has 61 references indexed in Scilit:
- Preclinical Corrective Gene Transfer in Xeroderma Pigmentosum Human Skin Stem CellsMolecular Therapy, 2012
- Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleasesNucleic Acids Research, 2012
- Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiersNucleic Acids Research, 2012
- A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicityNucleic Acids Research, 2011
- Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targetingNucleic Acids Research, 2011
- TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domainNucleic Acids Research, 2010
- Efficacy of Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2010
- Safe Selection of Genetically Manipulated Human Primary Keratinocytes with Very High Growth Potential Using CD24Molecular Therapy, 2007
- A combinatorial approach to create artificial homing endonucleases cleaving chosen sequencesNucleic Acids Research, 2006
- Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cellsNature Medicine, 2006